Teon Announces Trial Collaboration With Merck to Evaluate TT-816
18 Jan 2023 //
BUSINESSWIRE
Teon treats first subject in Phase I/II solid tumour therapy trial
02 Nov 2022 //
EUROPEANPHARMACEUTICALREVIEW
Teon Therapeutics Announces First Patient Treated in Pha1/2 Trial of TT-816
01 Nov 2022 //
BUSINESSWIRE
Former Janssen US oncology chief to lead Teon Therapeutics
09 Mar 2022 //
FIERCEBIOTECH